Fingerprint
Dive into the research topics of 'ERBB2 status and benefit from adjuvant tamoxifen in ER alpha-positive postmenopausal breast carcinoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
ERBB2 status and benefit from adjuvant tamoxifen in ER alpha-positive postmenopausal breast carcinoma
I Bieche, P Onody, F Lerebours, S Tozlu, K Hacene, C Andrieu, M Vidaud, M Tubiana-Hulin, F Spyratos, R Lidereau
Research output: Contribution to journal › Article (Academic Journal) › peer-review
8
Citations
(Scopus)